Section 143 CGST for Pharma: ITC-04 Quarterly Return Reconciliation

An illustrative Tier-1 pharma brand-owner running a Section 80-IE Sikkim unit as market authorisation holder — a persona shaped by the Sikkim manufacturing footprint that companies of the scale of Torrent Pharmaceuticals operate against the erstwhile Section 80-IE income-tax deduction regime — sends active pharmaceutical ingredients and intermediates with formulation specifications to a Baddi (Himachal Pradesh) third-party loan-licensee manufacturer of the scale that Wockhardt-tier operators run for tablet compression, coating, and blister packaging. The Sikkim principal closes its Q1 FY 2026-27 books (April to June 2026) with an illustrative 45 Rule 45 dispatch challans covering Rs 12.5 crore of API and intermediates outbound, 42 return-of-goods challans covering Rs 11.8 crore of processed formulations returned, and three challans covering Rs 0.7 crore still with the Baddi job-worker at 30 June 2026. Form GST ITC-04 for Q1 FY 2026-27 is due on the GST portal on or before 25 July 2026. This is Section 143 CGST job-work pharma ITC-04 quarterly return reconciliation at operating scale, and the discipline that keeps the challan-level dispatch register, the return-of-goods tracker, the Rule 45(4) deemed-supply ageing flag, the HSN 9988 job-work-charges IGST 12 percent input tax credit reconciliation, and the Section 43B(h) MSME 45-day payment aging simultaneously clean is what separates a principal whose Q1 filing runs on schedule from one that spends Q2 responding to a Rule 45(4) deemed-supply query and re-computing Section 50 interest on a mis-tracked challan.

Quick reference

The reconciliation in one paragraph

A pharma brand-owner that dispatches API and intermediates to a third-party loan-licensee manufacturer under Section 143 operates a four-surface reconciliation cascade. Surface one is the Rule 45 challan-level dispatch register — every outward movement travels under a delivery challan (not a tax invoice), no GST is paid on the outward leg, and the challan carries the receiving job-worker’s GSTIN, the HSN chapter of the goods (Chapter 29 for API, Chapter 30 for intermediates), the quantity and value, and the dispatch date that starts the one-year (inputs) or three-year (capital goods) return clock. Surface two is the return-of-goods challan register — every inward return matches to a source outward dispatch, and any outstanding at quarter-end is aged against the return-window deadline. Surface three is the Form GST ITC-04 quarterly filing itself — filed on the GST portal within twenty-five days from quarter-end (25 July for Q1, 25 October for Q2, 25 January for Q3, 25 April for Q4), presenting the four-movement reconciliation of goods sent to the job-worker, goods received back, goods sent job-worker to job-worker under the Section 143(1)(a) proviso, and goods still with the job-worker at quarter-close. Surface four is the job-work-charges invoice reconciliation — the job-worker’s HSN 9988 invoice attracts 12 percent GST (IGST for cross-state, CGST 6 percent + SGST 6 percent for intra-state), each invoice must match to the dispatch challan batch it covers, and the input tax credit claim reconciles to GSTR-2B. Overlaid across all four is the Section 43B(h) MSME 45-day payment aging on the job-work-charges payable — because a large share of Indian pharma third-party manufacturers are MSME-registered, the payable ledger sits inside the year-end disallowance risk if the 45-day ceiling is breached.

What the scenario looks like in India

The pharma loan-licensing and third-party manufacturing arrangement is a structural feature of the Indian formulation industry driven by two overlapping factors. The first is area-based tax incentive geography: Baddi (Himachal Pradesh) sits at the heart of a formulation cluster built during the erstwhile Section 80-IC income-tax and central-excise exemption regime, and Sikkim hosts a parallel cluster built against the Section 80-IE deduction for specified north-eastern and hill-state units. Brand-owners with Sikkim market authorisation holdings have an operating incentive to run production either at their own Sikkim unit or through a third-party manufacturer in a co-located tax-advantaged geography, and the API and intermediates often flow between plants owned by different legal entities. The second driver is capacity flexibility — a brand-owner ramping a therapy segment or servicing a state-tender contract can lean on a loan-licensee for surge capacity without committing capex to a new plant.

The illustrative persona this article walks through is a Tier-1 pharma brand-owner of the operating scale that Torrent Pharmaceuticals runs at its Sikkim unit — a market authorisation holder for a set of finished dosage forms manufactured under its own brand. The brand-owner runs its Section 80-IE Sikkim plant for a core portfolio and engages a Baddi-based loan-licensee (of the scale that Wockhardt or a comparable Tier-2 third-party manufacturer operates) for a specific set of tablets, capsules, and syrups. The API and intermediates are sourced by the Sikkim principal — either from its own backward-integrated API subsidiary or from third-party API suppliers — and dispatched under Rule 45 delivery challan to the Baddi loan-licensee for compression, coating, and blister packaging. The processed dosage forms return to the Sikkim premises against Rule 45 return-of-goods challan and are dispatched to the brand-owner’s warehouse network as normal outward supply under the brand-owner’s own tax invoice at the Chapter 30 5 percent rate post the 22 September 2025 rate reset. For a companion walkthrough of the underlying loan-licensing mechanics and the CDMO contract-cost architecture, the loan-licensing manufacturing and pharma CDMO reconciliation guide is the Wave A cornerstone; for the Chapter 29 API and Chapter 30 formulation HSN classification that the challan-level register carries, the API vs formulation HSN 2941/3003/3004 reconciliation walkthrough is the cross-reference.

The regulatory overlay — Section 143, Rule 45, Form GST ITC-04

Section 143 of the CGST Act 2017 permits a registered person (the principal) to send inputs or capital goods to a job-worker for job-work without payment of tax, and from there onward to a second job-worker under the proviso in Section 143(1)(a), and after processing to bring back the inputs within one year and the capital goods within three years (moulds, dies, jigs, fixtures and tools are excluded from the outer time limit). The outward and return movements travel under a Rule 45 delivery challan issued by the principal per Rule 55 — the challan carries the principal’s GSTIN, the job-worker’s GSTIN (or address if unregistered), the description of goods, the quantity and value, the HSN classification, the dispatch date, and the challan serial number. No tax invoice is issued on the outward or return leg because no supply is deemed to have occurred at the point of dispatch.

Rule 45(3) requires the principal to furnish the challan details in Form GST ITC-04 on or before the twenty-fifth day of the month succeeding the quarter. The return is filed on the GST portal per GSTIN — a brand-owner running multiple state units files one ITC-04 per state GSTIN reflecting challans dispatched from that state’s plant. The four movements reported are: (a) goods dispatched from the principal’s place of business to a job-worker; (b) goods received back from the job-worker; (c) goods dispatched from one job-worker to another under Section 143(1)(a); and (d) goods lying with the job-worker at quarter-close with challan age tracked.

Rule 45(4) is the operational trigger for the Section 143 deeming provision. Where the inputs are not received back within the one-year window or the capital goods within the three-year window, the goods so sent out shall be deemed to have been supplied by the principal to the job-worker on the day the goods were originally sent out. The consequence is a retrospective tax invoice, CGST and SGST (or IGST for inter-state) at the rate applicable to the goods, and interest under Section 50 CGST at 18 percent per annum computed from the deemed date up to the date of payment. For a Sikkim principal dispatching API under HSN Chapter 29 (2941 antibiotics at 5 percent) or intermediates under Chapter 30 (3003 bulk drug mixtures at 5 percent post 22 September 2025), the deemed supply on a cross-state dispatch to Baddi attracts IGST at 5 percent. The interest running from a dispatch date twelve-plus months back can materially exceed the base tax if the ageing is not proactively monitored.

The job-worker’s job-work charges are a supply of service under HSN 9988 (manufacturing services on physical inputs owned by others), attracting 12 percent GST for pharmaceutical job-work. Where the principal is in Sikkim and the job-worker in Himachal Pradesh (Baddi), the invoice is a cross-state supply and attracts IGST at 12 percent under Section 7 IGST Act 2017; intra-state it splits as CGST 6 percent plus SGST 6 percent. The principal claims input tax credit subject to Section 16 conditions — a valid tax invoice, actual receipt of the service, and the job-worker’s GSTR-1 filing flowing through to the principal’s GSTR-2B. Section 22 CGST governs the job-worker’s own GST registration requirement (Rs 20 lakh threshold, Rs 10 lakh in special-category states); below the threshold the job-worker operates unregistered and the job-work-charge leg does not carry GST, but the principal remains within the Rule 45 and ITC-04 discipline regardless.

A worked example — an illustrative Q1 FY 2026-27 ITC-04 filing

Illustrative — the following figures represent the operating pattern of a Tier-1 pharma brand-owner running a Section 80-IE Sikkim unit that engages a Baddi third-party loan-licensee for tablet compression, coating, and blister packaging. Public disclosures do not reveal per-challan dispatch and return values; cross-verify against your own challan-level register and job-work-charges invoice ledger before action.

The Sikkim principal’s Q1 FY 2026-27 (April to June 2026) challan-level movement register consolidates to the following position at quarter-end:

Across the same quarter, the Baddi job-worker raised job-work-charges invoices for the processing performed. Assuming an illustrative 8 percent job-work margin on the dispatched-material base for the batches returned, the job-work charges for Q1 total approximately Rs 0.94 crore. Because Sikkim-to-Baddi is a cross-state movement, the job-worker invoices IGST at 12 percent — Rs 0.11 crore IGST across the quarter’s invoices. The Sikkim principal claims this Rs 0.11 crore as input tax credit in its GSTR-3B for the tax period, reconciled to GSTR-2B against each of the job-worker’s individual invoices.

The Form GST ITC-04 filing for Q1 FY 2026-27 is due on or before 25 July 2026. It reports the 45 outward challans with dispatch date, HSN, quantity and value, the 42 return challans with receipt date and match to source outward challan, the three outstanding challans with age (all within three months of dispatch), and zero movements under the Section 143(1)(a) proviso. Because no challan crossed the one-year window, there is no Rule 45(4) deemed-supply crystallisation to report on the return.

On the Section 43B(h) MSME 45-day payable overlay, the Baddi loan-licensee is MSME-registered (Udyam certificate small-enterprise category). The Sikkim principal runs a 30-45-90 day payable aging on the Rs 0.94 crore job-work-charges plus GST for the quarter and schedules payment against the 45-day ceiling well before the 31 March 2027 year-end binding cutoff. For a companion walkthrough of the CDMO contract-margin architecture and the Section 92BA transfer-pricing overlay for intra-group loan-licensing arrangements, the API contract manufacturing margin reconciliation CDMO walkthrough is the cross-reference.

The illustrative Q1 close lands cleanly — ITC-04 filed by 25 July 2026, no deemed-supply crystallisation, full ITC claimed on the job-work-charges IGST, and payable aging under management. Q2 (due 25 October 2026) re-opens the ageing on the three outstanding challans carried forward, each now past six months and flagged against the twelfth-month deadline.

Common reconciliation breakages

Five breakages recur across Indian pharma brand-owners running the Section 143 CGST job-work cycle, each mapping to a specific control failure that a proper officer query or a Section 43B(h) year-end audit adjustment surfaces.

• Challan-level ageing not run at the eleventh month. The highest-cost breakage is a Rule 45(4) deemed-supply crystallisation on a challan that quietly crossed the one-year window. The consequence is a retrospective IGST liability at the applicable rate plus Section 50 interest at 18 percent per annum computed from the original dispatch date — the interest running from a twelve-to-fifteen-month-back deemed date can exceed 20 to 25 percent of the base value by the time the deeming is discovered. Discipline: the challan-level register carries an expected-return-date field set to eleven months from dispatch so preemptive return or transfer happens with a month’s runway.

• Return challan not matched to source outward challan. The four-movement ITC-04 reconciliation requires every inward return-of-goods to match to a specific outward dispatch challan (one-to-one for full-batch returns, one-to-many for split returns). Return challans that arrive without a clear match produce an ambiguous position on the ITC-04. Discipline: the return challan carries the source outward-dispatch challan reference at issue, or the receiving warehouse’s inbound receipt process captures the reference before the physical stock is put away.

• Job-work-charges invoice not matched to dispatch batch. The job-work-charge ITC claim requires a match between the job-worker’s HSN 9988 invoice and the specific dispatch challan (or challan set) that it covers. A mis-match — an invoice covering a different batch or quarter than the principal thinks — breaks the audit trail and exposes the ITC claim to a Section 16(2) challenge. Discipline: the job-work-charge invoice carries the source outward-dispatch challan reference and reconciles each quarter against the ITC-04 four-movement statement.

• Section 43B(h) MSME status not confirmed per job-worker. The 45-day payment ceiling applies only to job-workers registered as MSME micro or small enterprises. A brand-owner that treats every job-worker as MSME creates unnecessary working-capital pressure; one that treats every job-worker as non-MSME exposes the year-end payable to a Section 43B(h) disallowance. Discipline: the job-worker master carries the Udyam certificate reference and the enterprise category (micro / small / medium), refreshed annually because a job-worker crossing the small-to-medium threshold moves out of Section 43B(h) scope. The reconciliation failure mode analysis methodology walkthrough covers the payable-aging failure-mode class in the broader accounting-close context.

• Cross-state vs intra-state IGST vs CGST+SGST mis-classification. The HSN 9988 12 percent applies either as IGST (cross-state) or CGST 6 percent + SGST 6 percent (intra-state). A brand-owner with a multi-plant footprint engaging job-workers in multiple states can mis-classify when the principal-side GSTIN and job-worker-side GSTIN pairing is not clearly recorded on the invoice. Mis-classification produces an ITC break in the standing utilisation sequence. Discipline: the job-worker master and principal plant master both carry state, and the invoice processes cross-validate the pairing before the GST portion is booked.

How a reconciliation platform handles this

A purpose-built pharma reconciliation platform ingests the Rule 45 challan-level dispatch and return register, the job-worker HSN 9988 invoice ledger, the principal’s GSTR-2B ITC statement, and the job-worker master with MSME status flag — and produces a Form GST ITC-04 quarterly filing pack per principal GSTIN that reconciles the four movements at challan level, ages every outstanding challan against the one-year (inputs) and three-year (capital goods) return windows, triggers a preemptive return or transfer workflow at the eleventh month for any challan approaching the deeming date, matches each job-work-charges invoice to its source dispatch challan for the ITC audit trail, and runs the Section 43B(h) 45-day payable ageing per MSME-registered job-worker for the year-end disallowance forecast. The reconciliation playbook for monthly close operations pillar covers the standing close-cycle discipline that houses the ITC-04 quarterly workflow, and the pharma reconciliation software India money page is the commercial pillar. Match rate improvement of 51 to 88 percent on the challan-to-invoice and invoice-to-GSTR-2B legs, combined with an ISO 27001:2022 posture and DPDP Act 2023 aligned data handling, is what makes the platform an infrastructure investment for a pharma brand-owner running a multi-plant Section 143 CGST job-work network rather than a spreadsheet substitute.

Terra Insight Editorial Team Reconciliation Infrastructure

Content authored by practitioners with experience at Amazon India, Intuit QuickBooks, and the Tata Group. Meet the team →

Published 16 July 2026

Domain expertise

TDS Reconciliation GST Input Credit Platform Settlements NACH Batch Matching Bank Reconciliation Form 26AS Matching ERP Integrations Enterprise Finance Ops

Reviewed by

NK

Navin Krishnan

Managing Director & Founder — Terra Insight

Ex Amazon India · Intuit QuickBooks · Tata nexarc

ISO 27001:2022 Patent Pending Incorporated 2024